3.47 +0.54 (18.37%)
AGEN
| Trade AGEN now with |
Stock Details
Last Trade:3.47 Change:+0.54 (18.37%) Prev Close:2.93 Open: 2.94 Days Range:2.93 – 3.49 52 Week Range: 0.46 - 4.43 Volume:364958 P/E: N/AEPS:-1.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 2:51pm
Unusual 11 Midday Movers 02/08: (GUID) (CALX) (FFN) Higher; (SGI) (CDXS) (ONE) Lower
Unusual 11 Midday Movers 02/08: (GUID) (CALX) (FFN) Higher; (SGI) (CDXS) (ONE) Lower
Guidance Software, Inc. (NASDAQ: GUID) 37.1% HIGHER; reported Q4 EPS of $0.16, $0.07 better than the analyst estimate of $0.09. Revenue for the quarter came in at $29.9 million versus the consensus estimate of $28.31 million. Sees FY2012 EPS of... Read More
Recent Alert on 01/06/12 at 1:45pm
Unusual 11 Midday Movers 01/06: (BDSI) (REE) (SABA) (DNDN) Higher; (DRRX) (RFMD) (IART) Lower
Unusual 11 Midday Movers 01/06: (BDSI) (REE) (SABA) (DNDN) Higher; (DRRX) (RFMD) (IART) Lower
Recent Alert on 01/06/12 at 10:53am
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
Recent Alert on 12/01/11 at 9:13am
Global Hunter Securities Starts Agenus Inc. (AGEN) at Neutral; Advancing First-of-its-Kind Immunotherapies
Global Hunter Securities Starts Agenus Inc. (AGEN) at Neutral; Advancing First-of-its-Kind Immunotherapies
View AllRecent Press Releases
View AllRecent SEC Filings
SEC Filing on 02/07/12 at 11:42am
Form SC 13G/A AGENUS INC Filed by: INGALLS & SNYDER VALUE PARTNERS L P
Form SC 13G/A AGENUS INC Filed by: INGALLS & SNYDER VALUE PARTNERS L P
View AllRecent Blog Posts
Blog Posts on 01/16/12 at 4:23am
Pharma Leaders Emerging In Immunotherapy Approach To Fighting Glioblastoma
Pharma Leaders Emerging In Immunotherapy Approach To Fighting Glioblastoma


